Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Imaging
Published in: Cancer Imaging 1/2014

Open Access 01-12-2014 | Case series

MR imaging features of intracranial primary CNS lymphoma in immune competent patients

Authors: Asem Mansour, Monther Qandeel, Hikmat Abdel-Razeq, Hussain Ali Abu Ali

Published in: Cancer Imaging | Issue 1/2014

Login to get access

Abstract

We aimed to characterize specific MRI findings seen in immune competent patients with intracranial primary CNS lymphoma (PCNSL) and to determine their value in the management of such patients. Pre-treatment MRI examinations of 21 immunocompetent patients with biopsy-proven PCNSL were retrospectively evaluated. T1 and T2 signal characteristics as well as contrast enhancement features are described in all patients. Diffusion, perfusion and proton-MR-spectroscopy features are described in a subset of these patients. In the proper clinical and radiologic setting, suggesting the diagnosis of PCNSL can help institute proper treatment in a timely fashion and avoid unnecessary attempts at surgical resection and the associated morbidity.
Appendix
Available only for authorised users
Literature
1.
Küker W, Nägele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M, Herrlinger U: Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 2005, 72(2):169–177. doi:10.1007/s11060–004–3390–7 10.1007/s11060-004-3390-7PubMedCrossRef
2.
Haldorsen IS, Krakenes J, Krossnes BK, Mella O, Espeland A: CT and MR Imaging Features of Primary Central Nervous System Lymphoma in Norway, 1989–2003. AJNR Am J Neuroradiol 2009, 30(4):744–751. doi:10.3174/ajnr.A1447 10.3174/ajnr.A1447PubMedCrossRef
3.
Mohile NA, Abrey LE: Primary central nervous system lymphoma. Neurol Clin 2007, 25(4):1193–207. xi doi:10.1016/j.ncl.2007.07.001 10.1016/j.ncl.2007.07.001PubMedCrossRef
4.
Haldorsen IS, Espeland A, Larsson EM: Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging. AJNR Am J Neuroradiol 2011, 32(6):984–992. doi:10.3174/ajnr.A2171 10.3174/ajnr.A2171PubMedCrossRef
5.
Koeller KK, Smirniotopoulos JG, Jones RV: Primary central nervous system lymphoma: radiologic-pathologic correlation. Radiographics 1997, 17: 1497–526. 10.1148/radiographics.17.6.9397461PubMedCrossRef
6.
Fitzsimmons A, Upchurch K, Batchelor T: Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am 2005, 19: 689–703. 10.1016/j.hoc.2005.05.009PubMedCrossRef
7.
Hunt MA, Jahnke K, Murillo TP, Neuwelt EA: Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches. Neurosurg Focus 2006, 21(5):E3.PubMedCrossRef
8.
Raz E, Tinelli E, Antonelli M, Canevelli M, Fiorelli M, Bozzao L, Caramia F: MRI findings in lymphomatosis cerebri: description of a case and revision of the literature. J Neuroimaging 2011, 21(2):e183-e186. 10.1111/j.1552-6569.2010.00477.xPubMedCrossRef
9.
Go JL, Lee SC, Kim PE: Imaging of primary central nervous system lymphoma. Neurosurg Focus 2006, 21(5):E4.PubMedCrossRef
10.
Adachi K, Yamaguchi F, Node Y, Kobayashi S, Takagi R, Teramoto A: Neuroimaging of Primary Central Nervous System Lymphoma in Immunocompetent Patients: Comparison of Recent and Previous Findings. J Nippon Med Sch 2013, 80(3):174–183. 10.1272/jnms.80.174PubMedCrossRef
11.
Raz E, Zagzag D, Saba L, Mannelli L, Di Paolo PL, D'Ambrosio F, Knopp E: Cyst with a mural nodule tumor of the brain. Cancer Imaging 2012, 12: 237. 10.1102/1470-7330.2012.0028PubMedCentralPubMedCrossRef
12.
Masuoka J, Sakata S, Maeda K, Sugita Y: Adjacent epidermoid cyst and primary central nervous system lymphoma: case report. Surg Neurol 2008, 69(5):530–533. 10.1016/j.surneu.2007.02.057PubMedCrossRef
13.
Eichler AF, Batchelor TT: Primary central nervous system lymphoma: presentation, diagnosis and staging. Neurosurg Focus 2006, 21(5):E15.PubMedCrossRef
14.
Zacharia TT, Law M, Naidich TP, Leeds NE: Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 2008, 18: 411–17. 10.1111/j.1552-6569.2007.00231.xPubMedCrossRef
15.
Guo AC, Cummings TJ, Dash RC, Provenzale JM: Lymphomas and High-Grade Astrocytomas: Comparison of Water Diffusibility and Histologic Characteristics1. Radiology 2002, 224(1):177–183. 10.1148/radiol.2241010637PubMedCrossRef
16.
Barajas RF, Rubenstein JL, Chang JS, Hwang J, CHA S: Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System Lymphoma. AJNR Am J Neuroradiol 2010, 31(1):60–66. doi:10.3174/ajnr.A1750 10.3174/ajnr.A1750PubMedCentralPubMedCrossRef
17.
Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K: Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 2003, 342: 163–66. 10.1016/S0304-3940(03)00272-6PubMedCrossRef
18.
Taillibert S, Guillevin R, Menuel C, Sanson M, Hoang-Xuan K, Chiras J, Duffau H: Brain lymphoma: usefulness of the magnetic resonance spectroscopy. J Neurooncol 2008, 86: 225–29. 10.1007/s11060-007-9468-2PubMedCrossRef
19.
Chang L, Miller BL, McBride D, Cornford M, Oropilla G, Bunchthal S, Chiang F, Aronow H, Beck CK, Ernst T: Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995, 197: 525–31.PubMedCrossRef
Metadata
Title
MR imaging features of intracranial primary CNS lymphoma in immune competent patients
Authors
Asem Mansour
Monther Qandeel
Hikmat Abdel-Razeq
Hussain Ali Abu Ali
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2014
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/1470-7330-14-22

Other articles of this Issue 1/2014

Cancer Imaging 1/2014 Go to the issue

Research article

Neoadjuvant intra-arterial chemotherapy in patients with primary lacrimal adenoid cystic carcinoma

Research article

Added value of advanced over conventional magnetic resonance imaging in grading gliomas and other primary brain tumors

Research article

Morphological factors differentiating between early lung adenocarcinomas appearing as pure ground-glass nodules measuring ≤10 mm on thin-section computed tomography

Review

The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives

Review

Imaging acute complications in cancer patients: what should be evaluated in the emergency setting?

Research article

Endoscopic ultrasound – fine needle aspiration of 2-deoxy-2-[18F] fluoro-D-glucose avid lymph nodes seen on positron emission tomography- computed tomography –what looks like cancer may not always be so
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits